2023 Implementation of Long-Acting Drugs for Treatment and Prevention of HIV
Presentation Slides
- State of the Science: What We Know about Long-Acting Injectable Agents for Treatment of HIV
Presenter: Aadia I. Rana, MD - State of the Science: What We Know about Long-Acting Injectable Agents for HIV Prevention
Presenter: Colleen Kelley, MP, MPH - Resistance in Long-Acting Therapy for Prevention and Treatment: Uncommon Outcome or Achilles Heel
Presenter: Joseph J. Eron, Jr, MD - Annoying But Necessary: Navigating the Operational Challenges of Long-Acting Treatment and Prevention Strategies
Presenter: Joshua P. Havens, PharmD - Challenging Cases in Long-Acting Treatment and Prevention: What Would You Do?
Presenter: Raphael J. Landovitz, MD, MSc
Panelists: Peter L. Anderson PharmD, Kevin L. Ard, MD, MPH, Carolyn Chu, MD, MSc, Joseph J. Eron, Jr, MD, Joshua P. Havens, PharmD, and Aniruddha Hazra, MD